期刊文献+

和厚朴酚的药理作用及其抗肿瘤的机制研究进展 被引量:11

Research Progress on the Pharmacological Function and Antitumor Mechanism of Honokiol
下载PDF
导出
摘要 和厚扑酚是中药厚朴中分离的带有烯丙基的连苯二酚类化合物,具有广泛的药理作用,包括抗炎、抗菌、抗血小板凝集、保护心脑血管系统作用、抗焦虑、抗癫痫、肌肉松弛、抗氧化、抗肿瘤、改善胃肠功能紊乱及抗肿瘤作用等。因和厚朴酚毒性较低,其抗肿瘤作用成为近年研究的热点。它具有诱导肿瘤细胞凋亡、促进肿瘤细胞分化、抑制肿瘤细胞增殖、抑制肿瘤转移、抗肿瘤血管形成、逆转肿瘤多药耐药等作用。本文对其药理作用及抗肿瘤机制进行综述。 Honokiol is isolated from traditional Chinese medicine magnolia bark which has Allyl connection with hydroquinone compounds,with a wide range of pharmacological effects, including antiinflammatory, antibacterial, anti-platelet aggregation, anti-anxiety, epilepsy, muscle relaxants, anti-oxidation, anti-tumor,protects cardiovascular and cerebrovascular systems. Honokiol by a much less toxic, and its anti-tumor effect become a research hotspet in recent years. It can induce tumor cell apoptosis and promote tumor cell differentiation, inhibit tumor cell proliferation and metastasis, anti-tumor angiogenesis, tumor multidrug resistance reversal effects. In this paper, its pharmacological effects and mechanism of anti-tumor were reviewed.
作者 王冬娥 陆羡
出处 《医学综述》 2009年第11期1725-1727,共3页 Medical Recapitulate
关键词 和厚朴酚 药理作用 肿瘤 Honokiol Pharmacological action Tumor
  • 相关文献

参考文献3

二级参考文献70

  • 1赵纯森,黄俊斌,周茂繁.厚朴叶中抑菌活性成分鉴别及其防病效果[J].华中农业大学学报,1994,13(4):373-377. 被引量:77
  • 2Vizler C, Rosato A, Calderazzo F et al. Therapeutic effect of interleukin-12 on mouse haemangiosarcomas is not associated with an increased anti-tumor cytotoxic T-lymphocyte activity [J]. Br J Cancer, 1998, 77 (4):656-662. 被引量:1
  • 3Kanegane C, Sgadari C, Kanegane H et al. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12 [J]. J Leukoc Biol, 1998, 64(3):384-392. 被引量:1
  • 4Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by interleukin-12 electro-gene theprapy [J]. J Natl Cancer Inst, 2002, 94(10):762-768. 被引量:1
  • 5Dias S, Boyd R, Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model[J]. Int J Cancer, 1998, 78(3):361-365. 被引量:1
  • 6Duda DG, Sunamura M, Lozonschi L et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin-12 [J]. Cancer Res, 2000, 60(4):1111-1116. 被引量:1
  • 7Nanni P, Rossi I, De Giovanni C et al. Interleukin-12 gene therapy of MHC-negative murine melanoma metastases [J]. Cancer Res, 1995, 58(6):1225-1230. 被引量:1
  • 8Tasaki K, Yoshida Y, Maeda T et al. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells [J].Cancer Gene Ther, 2000, 7(2):247-254. 被引量:1
  • 9Andrews KJ, Ribas A, Butterfield LH et al. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocelluar carcinoma model is not dependent on CD1-restricted natural killer T cells [J].Cancer Res, 2000, 60(22):6457-6464. 被引量:1
  • 10Boggio K, Di Carlo E, Rovero S et al. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice [J].Cancer Res, 2000, 60(2):359-364. 被引量:1

共引文献73

同被引文献80

引证文献11

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部